IL-15 cis Presentation Is Required for Optimal NK Cell Activation in Lipopolysaccharide-Mediated Inflammatory Conditions

Cell Reports

Volumn 4, Issue 6, 2013, Pages 1235-1249

  Zanoni, Ivan ^a   Spreafico, Roberto ^a   Bodio, Caterina ^a   DiGioia, Marco ^a   Cigni, Clara ^a   Broggi, Achille ^a   Gorletta, Tatiana ^a   Caccia, Michele ^a   Chirico, Giuseppe ^a   Sironi, Laura ^a   Collini, Maddalena ^a   Colombo, Mario P ^b   Garbi, Natalio ^c   Granucci, Francesca ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 18; INTERLEUKIN 2; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE ACTIVATION; MOLECULAR MECHANICS; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; DENDRITIC CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-15; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84884558141     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.08.021     Document Type: Article

References (80)

1. Andrews D.M., Scalzo A.A., Yokoyama W.M., Smyth M.J., Degli-Esposti M.A. Functional interactions between dendritic cells and NK cells during viral infection. Nat. Immunol. 2003, 4:175-181.
2. Becker I., Salaiza N., Aguirre M., Delgado J., Carrillo-Carrasco N., Kobeh L.G., Ruiz A., Cervantes R., Torres A.P., Cabrera N., et al. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol. Biochem. Parasitol. 2003, 130:65-74.
3. Berard M., Brandt K., Bulfone-Paus S., Tough D.F. IL-15 promotes the survival of naive and memory phenotype CD8+ Tcells. J.Immunol. 2003, 170:5018-5026.
4. Beuneu H., Deguine J., Breart B., Mandelboim O., Di Santo J.P., Bousso P. Dynamic behavior of NK cells during activation in lymph nodes. Blood 2009, 114:3227-3234.
5. Blomberg K., Hautala R., Lövgren J., Mukkala V.M., Lindqvist C., Akerman K. Time-resolved fluorometric assay for natural killer activity using target cells labelled with a fluorescence enhancing ligand. J.Immunol. Methods 1996, 193:199-206.
6. Boehm U., Klamp T., Groot M., Howard J.C. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 1997, 15:749-795.
7. Brilot F., Strowig T., Roberts S.M., Arrey F., Münz C. NK cell survival mediated through the regulatory synapse with human DCs requires IL-15Ralpha. J.Clin. Invest. 2007, 117:3316-3329.
8. Burkett P.R., Koka R., Chien M., Chai S., Boone D.L., Ma A. Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ Tcell homeostasis. J.Exp. Med. 2004, 200:825-834.
9. Castro I., Yu A., Dee M.J., Malek T.R. The basis of distinctive IL-2- and IL-15-dependent signaling: weak CD122-dependent signaling favors CD8+ T central-memory cell survival but not T effector-memory cell development. J.Immunol. 2011, 187:5170-5182.
10. Chaix J., Tessmer M.S., Hoebe K., Fuséri N., Ryffel B., Dalod M., Alexopoulou L., Beutler B., Brossay L., Vivier E., Walzer T. Cutting edge: Priming of NK cells by IL-18. J.Immunol. 2008, 181:1627-1631.
11. Chalifour A., Jeannin P., Gauchat J.F., Blaecke A., Malissard M., N'Guyen T., Thieblemont N., Delneste Y. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production. Blood 2004, 104:1778-1783.
12. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 2009, 27:519-550.
13. Dunn P.L., North R.J. Early gamma interferon production by natural killer cells is important in defense against murine listeriosis. Infect. Immun. 1991, 59:2892-2900.
14. Ebihara T., Azuma M., Oshiumi H., Kasamatsu J., Iwabuchi K., Matsumoto K., Saito H., Taniguchi T., Matsumoto M., Seya T. Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation. J.Exp. Med. 2010, 207:2675-2687.
15. Fehniger T.A., Shah M.H., Turner M.J., VanDeusen J.B., Whitman S.P., Cooper M.A., Suzuki K., Wechser M., Goodsaid F., Caligiuri M.A. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J.Immunol. 1999, 162:4511-4520.
16. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M., Münz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J.Exp. Med. 2002, 195:343-351.
17. Ferlazzo G., Morandi B., D'Agostino A., Meazza R., Melioli G., Moretta A., Moretta L. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur. J. Immunol. 2003, 33:306-313.
18. Ferlazzo G., Pack M., Thomas D., Paludan C., Schmid D., Strowig T., Bougras G., Muller W.A., Moretta L., Münz C. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 2004, 101:16606-16611.
19. Fernandez N.C., Lozier A., Flament C., Ricciardi-Castagnoli P., Bellet D., Suter M., Perricaudet M., Tursz T., Maraskovsky E., Zitvogel L. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses invivo. Nat. Med. 1999, 5:405-411.
20. Fink L.N., Zeuthen L.H., Christensen H.R., Morandi B., Frøkiaer H., Ferlazzo G. Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses. Int. Immunol. 2007, 19:1319-1327.
21. French A.R., Yokoyama W.M. Natural killer cells and viral infections. Curr. Opin. Immunol. 2003, 15:45-51.
22. French A.R., Sjölin H., Kim S., Koka R., Yang L., Young D.A., Cerboni C., Tomasello E., Ma A., Vivier E., et al. DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections. J.Immunol. 2006, 177:4981-4990.
23. Gorski K.S., Waller E.L., Bjornton-Severson J., Hanten J.A., Riter C.L., Kieper W.C., Gorden K.B., Miller J.S., Vasilakos J.P., Tomai M.A., Alkan S.S. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists. Int. Immunol. 2006, 18:1115-1126.
24. Granucci F., Vizzardelli C., Pavelka N., Feau S., Persico M., Virzi E., Rescigno M., Moro G., Ricciardi-Castagnoli P. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat. Immunol. 2001, 2:882-888.
25. Granucci F., Zanoni I., Pavelka N., Van Dommelen S.L., Andoniou C.E., Belardelli F., Degli Esposti M.A., Ricciardi-Castagnoli P. A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J.Exp. Med. 2004, 200:287-295.
26. Hart O.M., Athie-Morales V., O'Connor G.M., Gardiner C.M. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. J.Immunol. 2005, 175:1636-1642.
27. Hochweller K., Striegler J., Hämmerling G.J., Garbi N. A novel CD11c.DTR transgenic mouse for depletion of dendritic cells reveals their requirement for homeostatic proliferation of natural killer cells. Eur. J. Immunol. 2008, 38:2776-2783.
28. Horowitz A., Stegmann K.A., Riley E.M. Activation of natural killer cells during microbial infections. Front. Immunol. 2012, 2:88.
29. Huntington N.D., Legrand N., Alves N.L., Jaron B., Weijer K., Plet A., Corcuff E., Mortier E., Jacques Y., Spits H., Di Santo J.P. IL-15 trans-presentation promotes human NK cell development and differentiation invivo. J.Exp. Med. 2009, 206:25-34.
30. Ikawa M., Yamada S., Nakanishi T., Okabe M. 'Green mice' and their potential usage in biological research. FEBS Lett. 1998, 430:83-87.
31. Ikemizu S., Chirifu M., Davis S.J. IL-2 and IL-15 signaling complexes: different but the same. Nat. Immunol. 2012, 13:1141-1142.
32. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J.Exp. Med. 1992, 176:1693-1702.
33. Jung S., Unutmaz D., Wong P., Sano G., De los Santos K., Sparwasser T., Wu S., Vuthoori S., Ko K., Zavala F., et al. Invivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ Tcells by exogenous cell-associated antigens. Immunity 2002, 17:211-220.
34. Koka R., Burkett P., Chien M., Chai S., Boone D.L., Ma A. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells. J.Immunol. 2004, 173:3594-3598.
35. Lanier L.L. NK cell recognition. Annu. Rev. Immunol. 2005, 23:225-274.
36. Lapaque N., Walzer T., Méresse S., Vivier E., Trowsdale J. Interactions between human NK cells and macrophages in response to Salmonella infection. J.Immunol. 2009, 182:4339-4348.
37. Lauzon N.M., Mian F., MacKenzie R., Ashkar A.A. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. Cell. Immunol. 2006, 241:102-112.
38. Lauzon N.M., Mian F., Ashkar A.A. Toll-like receptors, natural killer cells and innate immunity. Adv. Exp. Med. Biol. 2007, 598:1-11.
39. Lucas M., Schachterle W., Oberle K., Aichele P., Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007, 26:503-517.
40. Ma A., Koka R., Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 2006, 24:657-679.
41. Martín-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., Sallusto F. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 2004, 5:1260-1265.
42. McCartney S., Vermi W., Gilfillan S., Cella M., Murphy T.L., Schreiber R.D., Murphy K.M., Colonna M. Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells. J.Exp. Med. 2009, 206:2967-2976.
43. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
44. Miyake T., Kumagai Y., Kato H., Guo Z., Matsushita K., Satoh T., Kawagoe T., Kumar H., Jang M.H., Kawai T., et al. Poly I:C-induced activation of NK cells by CD8 alpha+ dendritic cells via the IPS-1 and TRIF-dependent pathways. J.Immunol. 2009, 183:2522-2528.
45. Moretta L., Ferlazzo G., Bottino C., Vitale M., Pende D., Mingari M.C., Moretta A. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol. Rev. 2006, 214:219-228.
46. Mortier E., Woo T., Advincula R., Gozalo S., Ma A. IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J.Exp. Med. 2008, 205:1213-1225.
47. Muntasell A., Magri G., Pende D., Angulo A., López-Botet M. Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection. Blood 2010, 115:5170-5179.
48. Murphy W.J., Parham P., Miller J.S. NK cells-from bench to clinic. Biol. Blood Marrow Transplant. 2012, 18(Suppl):S2-S7.
49. Netea M.G., Nold-Petry C.A., Nold M.F., Joosten L.A., Opitz B., van der Meer J.H., van de Veerdonk F.L., Ferwerda G., Heinhuis B., Devesa I., et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 2009, 113:2324-2335.
50. Newman K.C., Riley E.M. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat. Rev. Immunol. 2007, 7:279-291.
51. Nguyen K.B., Cousens L.P., Doughty L.A., Pien G.C., Durbin J.E., Biron C.A. Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat. Immunol. 2000, 1:70-76.
52. Nguyen K.B., Salazar-Mather T.P., Dalod M.Y., Van Deusen J.B., Wei X.Q., Liew F.Y., Caligiuri M.A., Durbin J.E., Biron C.A. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J.Immunol. 2002, 169:4279-4287.
53. Olsen S.K., Ota N., Kishishita S., Kukimoto-Niino M., Murayama K., Uchiyama H., Toyama M., Terada T., Shirouzu M., Kanagawa O., Yokoyama S. Crystal Structure of the interleukin-15.interleukin-15 receptor alpha complex: insights into trans and cis presentation. J.Biol. Chem. 2007, 282:37191-37204.
54. Orange J.S., Biron C.A. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and Tcell responses in contrasting viral infections. J.Immunol. 1996, 156:1138-1142.
55. Pisegna S., Pirozzi G., Piccoli M., Frati L., Santoni A., Palmieri G. p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. Blood 2004, 104:4157-4164.
56. Pohl T., Krause H., Dürkop H., Paus R., Bulfone-Paus S. Retraction: The IL-15Rα chain signals through association with Syk in human B cells. J.Immunol. 2011, 186:2681.
57. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
58. Pontiroli F., Dussurget O., Zanoni I., Urbano M., Beretta O., Granucci F., Ricciardi-Castagnoli P., Cossart P., Foti M. The timing of IFNβ production affects early innate responses to Listeria monocytogenes and determines the overall outcome of lethal infection. PLoS ONE 2012, 7:e43455.
59. Ranson T., Vosshenrich C.A., Corcuff E., Richard O., Müller W., Di Santo J.P. IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood 2003, 101:4887-4893.
60. Regner M., Pavlinovic L., Young N., Müllbacher A. Invivo elimination of MHC-I-deficient lymphocytes by activated natural killer cells is independent of granzymes A and B. PLoS ONE 2011, 6:e23252.
61. Ring A.M., Lin J.X., Feng D., Mitra S., Rickert M., Bowman G.R., Pande V.S., Li P., Moraga I., Spolski R., et al. Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15. Nat. Immunol. 2012, 13:1187-1195.
62. Robinson D., Shibuya K., Mui A., Zonin F., Murphy E., Sana T., Hartley S.B., Menon S., Kastelein R., Bazan F., O'Garra A. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 1997, 7:571-581.
63. Romo N., Magri G., Muntasell A., Heredia G., Baía D., Angulo A., Guma M., López-Botet M. Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization. J.Leukoc. Biol. 2011, 90:717-726.
64. Rowley J., Monie A., Hung C.F., Wu T.C. Expression of IL-15RA or an IL-15/IL-15RA fusion on CD8+ Tcells modifies adoptively transferred T-cell function in cis. Eur. J. Immunol. 2009, 39:491-506.
65. Schmidt K.N., Leung B., Kwong M., Zarember K.A., Satyal S., Navas T.A., Wang F., Godowski P.J. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J.Immunol. 2004, 172:138-143.
66. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
67. Sen G.C. Viruses and interferons. Annu. Rev. Microbiol. 2001, 55:255-281.
68. Sivori S., Falco M., Della Chiesa M., Carlomagno S., Vitale M., Moretta L., Moretta A. CpG and double-stranded RNA trigger human NK cellsby Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc. Natl. Acad. Sci. USA 2004, 101:10116-10121.
69. Sivori S., Carlomagno S., Moretta L., Moretta A. Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate humanNK cells. Eur. J. Immunol. 2006, 36:961-967.
70. Sivori S., Falco M., Carlomagno S., Romeo E., Moretta L., Moretta A. Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors. Int. Immunol. 2007, 19:1341-1348.
71. Sun J.C., Ma A., Lanier L.L. Cutting edge: IL-15-independent NK cell response to mouse cytomegalovirus infection. J.Immunol. 2009, 183:2911-2914.
72. Takeda K., Oshima H., Hayakawa Y., Akiba H., Atsuta M., Kobata T., Kobayashi K., Ito M., Yagita H., Okumura K. CD27-mediated activation of murine NK cells. J.Immunol. 2000, 164:1741-1745.
73. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999, 11:443-451.
74. Tsujimoto H., Uchida T., Efron P.A., Scumpia P.O., Verma A., Matsumoto T., Tschoeke S.K., Ungaro R.F., Ono S., Seki S., et al. Flagellin enhances NK cell proliferation and activation directly and through dendritic cell-NK cell interactions. J.Leukoc. Biol. 2005, 78:888-897.
75. Walzer T., Bléry M., Chaix J., Fuseri N., Chasson L., Robbins S.H., Jaeger S., André P., Gauthier L., Daniel L., et al. Identification, activation, and selective invivo ablation of mouse NK cells via NKp46. Proc. Natl. Acad. Sci. USA 2007, 104:3384-3389.
76. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K., Akira S. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J.Immunol. 2002, 169:6668-6672.
77. Zanoni I., Foti M., Ricciardi-Castagnoli P., Granucci F. TLR-dependent activation stimuli associated with Th1 responses confer NK cell stimulatory capacity to mouse dendritic cells. J.Immunol. 2005, 175:286-292.
78. Zanoni I., Ostuni R., Marek L.R., Barresi S., Barbalat R., Barton G.M., Granucci F., Kagan J.C. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 2011, 147:868-880.
79. Zanoni I., Bodio C., Broggi A., Ostuni R., Caccia M., Collini M., Venkatesh A., Spreafico R., Capuano G., Granucci F. Similarities and differences of innate immune responses elicited by smooth and rough LPS. Immunol. Lett. 2012, 142:41-47.
80. Zhang X., Sun S., Hwang I., Tough D.F., Sprent J. Potent and selective stimulation of memory-phenotype CD8+ Tcells invivo by IL-15. Immunity 1998, 8:591-599.